Ajdovšcina, Slovenia, June 2, 2015 / B3C newswire / -- BIA Separations is proud to announce the expansion of its distribution network in China through collaboration with Guangzhou Bairui Medicine (hereinafter as Bairui).

As of 15th May, BIA Separations' analytical and preparative CIM monolith columns, including CIMac™, CIM® and CIMmultus™ will also be available to the Chinese customers through Bairui as well as services which will be performed by a joint group of experts of both companies.

About Bairui Bairui is a GSP certified pharmaceutical company who is engaged in the business of manufacturing, promotiom and distribution of various pharmaceutical products in the territory of People’s Republic of China with 15 years of experience. Bairui’s multi-service approach includes:

• Import & Export of Intermediates, API and Finished dosage
• Promotion & Market Development
• Drug registration in and out of China
• ANDA filing in US 

About BIA Separations BIA Separations is the only worldwide developer and manufacturer of CIM Convective Interaction MediaR -- short monolithic chromatographic columns optimized for the separation and purification of large bio-molecules and viral particles on the laboratory and industrial scale.

Contacts

Lidija Urbas, Ph.D. BIA Separations Tel.: +386 59 699 500 marketing@monoliths.com www.biaseparations.com

Allen Gu Guangzhou Bairui Medicine Co., Ltd Tel.: +86 20 37652938 Add:  12AB, Xin Yu Building, No.81, Nonglinxia Road, Guangzhou, China. allen@gzbr.com.cn www.gzbr.com.cn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.